CLINICAL_TRIALS
trial_result
· 2021-04-13
Clinical Trial Update: A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02 [Phase 1]
Summary
Phase 1 study assessing how renal impairment affects pharmacokinetics of ELX-02 has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eloxx Pharmaceuticals, Inc. | Conditions: Impaired Renal Function | Phase 1 | Status: COMPLETED | Results posted: 2021-04-13